Compare Crescentis Capit with Similar Stocks
Stock DNA
Non Banking Financial Company (NBFC)
INR 211 Cr (Micro Cap)
753.00
22
0.00%
0.00
0.34%
2.59
Total Returns (Price + Dividend) 
Latest dividend: 1.0000 per share ex-dividend date: Sep-07-2011
Risk Adjusted Returns v/s 
Returns Beta
News

Som Datt Finance Corporation Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
Som Datt Finance Corporation Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Hold to Sell as of 20 April 2026. This decision follows a comprehensive reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite some positive quarterly results and market-beating returns over the past year, the downgrade reflects concerns over long-term fundamentals, expensive valuation metrics, and a shift in technical indicators.
Read full news article
Som Datt Finance Corporation Ltd Upgraded to Hold on Technical and Financial Improvements
Som Datt Finance Corporation Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating upgraded from Sell to Hold as of 15 Apr 2026. This revision reflects a notable improvement in technical indicators alongside positive quarterly financial results, despite lingering concerns over valuation and long-term fundamentals.
Read full news article
Som Datt Finance Corporation Ltd is Rated Sell
Som Datt Finance Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 April 2026, providing investors with the latest insights into its performance and outlook.
Read full news article Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13-Apr-2026 | Source : BSEPlease find attached herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026 along with the certificate received from RTA.
Intimation Of In-Principal Approval For 1300000 Equity Shares Of Rs.10/- Each To Be Issued Under Crescentis Capital Limited Employees Stock Option Scheme 2025.
04-Apr-2026 | Source : BSEPlease find the attached for In-principle approval received from BSE.
Disclosure By Promoter And Promoter Group Under Reg 31(4) Of SEBI (SAST) Regulations 2011
02-Apr-2026 | Source : BSEDisclosure by Promoter and Promoter group under Reg 31(4) of SEBI (SAST) Regulations 2011
Corporate Actions 
No Upcoming Board Meetings
Crescentis Capital Ltd has declared 10% dividend, ex-date: 07 Sep 11
No Splits history available
No Bonus history available
Crescentis Capital Ltd has announced 7:10 rights issue, ex-date: 06 Jun 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Dr. Bhaskara Rao Bollineni (68.8%)
Soptex Developements Limited (1.45%)
20.11%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 1,330.77% vs -94.75% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 347.92% vs -114.33% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 4.83% vs -28.08% in Sep 2024
Growth in half year ended Sep 2025 is 8.71% vs -54.56% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 1,175.71% vs -93.86% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 346.06% vs -117.61% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -120.09% vs 1,021.64% in Mar 2024
YoY Growth in year ended Mar 2025 is -144.79% vs 1,580.56% in Mar 2024






